Retrospective Study
Copyright ©The Author(s) 2019.
World J Clin Cases. Sep 26, 2019; 7(18): 2712-2721
Published online Sep 26, 2019. doi: 10.12998/wjcc.v7.i18.2712
Table 3 Univariate and multivariate analyses of prognostic factors for patients with pathological stage IIIA gastric cancer
VariableUnivariate analysis
Multivariate analysis
Hazard ratio (95%CI)P-valueHazard ratio (95%CI)P-value
Status of 14v dissection0.0270.342
14vD (-)1 (ref)1 (ref)
14vD (+)0.39 (0.17-0.90)0.61 (0.22-1.70)
Age group0.3310.018
< 65 yr1 (ref)1 (ref)
≥ 65 yr1.53 (0.65-3.64)7.23 (1.41-37.06)
Gender0.9860.930
Male1 (ref)1 (ref)
Female0.99 (0.44-2.24)1.05 (0.36-3.09)
Tumor size0.0910.091
< 4 cm1 (ref)1 (ref)
≥ 4 cm0.46 (0.19-1.13)0.37 (0.12-1.17)
Histologic grade0.2200.091
Differentiated1 (ref)1 (ref)
Undifferentiated1.71 (0.73-4.02)2.71 (0.85-8.60)
pT stage0.1540.006
T2-31 (ref)1 (ref)
T41.35 (0.89-2.04)14.15 (2.11-95.06)
pN stage0.8860.335
N0-11 (ref)1 (ref)
N20.86 (0.33-2.25)1.77 (0.55-5.72)
N3a0.74 (0.22-2.49)3.69 (0.64-21.37)
Postoperative chemotherapy0.9360.586
No1 (ref)1 (ref)
Yes0.96 (0.39-2.37)0.75 (0.27-2.11)